ACE inhibitor use was associated with lower serum dehydroepiandrosterone concentrations in older men.
BACKGROUND
Angiotensin converting enzyme (ACE) activity may influence the production of adrenal androgen precursors and testosterone. Use of ACE inhibitors may therefore have an influence on serum sex hormone concentrations in older men.


METHODS
1486 out of 2,000 community-dwelling Chinese men aged 65years who participated in a cohort study were randomly selected to have archived fasting morning serum analyzed for androgen precursors and sex hormones. DNA was extracted from whole blood and analyzed for ACE gene I/D polymorphism.


RESULTS
Subjects with the ACE gene D allele (higher ACE activity) had higher serum dehydroepiandrosterone (DHEA) sulphate and DHEA than those with I/I genotype (P=0.014 and 0.018 respectively, Mann Whitney test). These differences were not significant after Bonferroni correction. Among those with history of hypertension, but without diabetes mellitus or cardiac failure, users of ACE inhibitors had significantly lower serum DHEA (median 1.78 versus 1.49ng/ml in non-users, P=0.0074, Mann Whitney test) and also tended to have lower serum androstenedione and androst-5-ene-3beta,17beta-diol (0.68 versus 0.72ng/ml in non-users; 552.4 versus 624.1pg/ml respectively, both P values <0.05). Serum testosterone and estradiol were not significantly changed.


CONCLUSIONS
ACE inhibitor use was associated with lower serum DHEA in older men.
Kwok
T
T
Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China. tkwok@cuhk.edu.hk
Ohlsson
C
C
Vandenput
L
L
Tang
N
N
Zhang
Y F
YF
Tomlinson
B
B
Leung
P C
PC
D000368:Aged; D000483:Alleles; D000728:Androgens / Q000097:blood; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D002681:China / Q000208:ethnology; D003687:Dehydroepiandrosterone / Q000097:blood*; D004967:Estrogens / Q000097:blood; D005838:Genotype; D006801:Humans; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000235:genetics / Q000378:metabolism*; D011110:Polymorphism, Genetic
D000728:Androgens; D000806:Angiotensin-Converting Enzyme Inhibitors; D004967:Estrogens; D003687:Dehydroepiandrosterone; D007703:Peptidyl-Dipeptidase A
Atherosclerosis. 2008 Feb;196(2):682-8
17765903
Biochem J. 1993 Feb 15;290 ( Pt 1):33-40
8382480
Physiol Res. 2005;54(2):151-7
15544418
Endocrinology. 2004 Oct;145(10):4703-11
15231706
Semin Reprod Med. 2004 Nov;22(4):361-8
15635503
J Clin Epidemiol. 1993 Feb;46(2):153-62
8437031
J Clin Endocrinol Metab. 2000 May;85(5):1834-40
10843161
Diabetes Care. 2004 Apr;27(4):861-8
15047639
J Biol Chem. 1988 Apr 15;263(11):5070-4
2833494
J Steroid Biochem. 1982 Jun;16(6):801-10
7202083
J Clin Endocrinol Metab. 1997 Aug;82(8):2396-402
9253307
N Engl J Med. 2006 Oct 19;355(16):1647-59
17050889
Endocr Rev. 2002 Jun;23(3):279-302
12050121
J Hypertens. 2004 May;22(5):937-44
15097233
J Hypertens Suppl. 2006 Mar;24(1):S131-7
16601566
J Clin Invest. 1990 Oct;86(4):1343-6
1976655
Bone. 2006 Apr;38(4):584-8
16257280
J Steroid Biochem Mol Biol. 2006 Jun;99(4-5):182-8
16621522
J Clin Endocrinol Metab. 1998 Jun;83(6):2104-9
9626146
Obes Res. 2001 Feb;9(2):97-101
11316352
Hypertens Res. 1998 Dec;21(4):279-82
9877521
Circulation. 1995 Sep 15;92(6):1387-8
7664416
Br J Dermatol. 2007 Apr;156(4):642-5
17263818
J Biol Chem. 2009 Feb 20;284(8):4857-64
19004830
Hiroshima J Med Sci. 2008 Mar;57(1):17-25
18578363
Am J Physiol. 1983 Dec;245(6):R805-10
6318575
J Steroid Biochem Mol Biol. 2009 Jan;113(1-2):52-6
19073258
Eur J Clin Chem Clin Biochem. 1997 Jun;35(6):411-4
9228322
Endocrinol Jpn. 1984 Dec;31(6):741-7
6241882